Life Sciences

Cincinnati: A Market Defined by Industrial Strength, Life Sciences Growth

by Kristin Harlow July 30, 2026

By Kimm Lauterbach, REDI Cincinnati Shaped by its strong German heritage, brewing tradition and historic role as the nation’s pork-processing capital, earning the nickname “Porkopolis,” the Cincinnati region has long been defined by industry, entrepreneurship and innovation. That legacy of reinvention has transformed Cincinnati into one of the Midwest’s most resilient and strategically positioned economic development markets. Anchored by a diverse economy, a central location within a one-day drive of nearly 60 percent of the U.S. population and a growing concentration of advanced industries, the region is experiencing sustained investment across industrial and life sciences. Unlike many peer markets that are dependent on a single industry, Cincinnati benefits from a balanced economic base led by advanced manufacturing, life sciences, aerospace and aviation, food and beverage and logistics. For the first quarter of 2026, REDI Cincinnati has welcomed the highest number of site visits since our inception. Industrial powerhouse Industrial real estate remains the strongest-performing commercial sector in the Cincinnati market. Cincinnati’s industrial vacancy rate stood at approximately 5.4 percent during the first quarter of 2026, according to Cushman & Wakefield, reflecting a healthy and balanced market despite significant inventory growth over the last several years. Positive absorption has continued, …

July 30, 2026

California Life Sciences Loans Western

Breakthrough Properties, Tishman Speyer Provide $90M Loan for 538,000 SF Life Sciences Campus in San Diego

by Amy Works July 24, 2026

SAN DIEGO — Breakthrough Properties and Tishman Speyer have provided a $90 million mezzanine bridge loan for Aperture Del Mar, a Class A life sciences campus in San Diego. The borrower, Gemdale USA, will use the proceeds to refinance an existing loan. Totaling 538,000 square feet, the four-building lab and office campus is fully occupied by Neurocrine Biosciences, a biopharmaceutical company. The campus features a standalone fitness center with a yoga studio and juice bar, outdoor event lawn, private patios, courtyard and a 1,500-stall parking garage. Aperture Del Mar serves as Neurocrine’s mission-critical global headquarters as part of a lease that funds through 2036. Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, develops and owns life sciences real estate in San Diego and other markets around the world. Tishman Speyer directly participated in the financing through its recently established debt platform.

July 24, 2026

Leasing Activity Life Sciences Massachusetts Northeast Office

Living Proof Signs 14,085 SF Office, Life Sciences Lease in Boston’s Seaport District

by Taylor Williams June 24, 2026

BOSTON — Living Proof has signed a 14,085-square-foot lease in Boston’s Seaport District. The provider of hair care products will relocate its operations from the Innovation & Design Building to the entire fifth floor of the office and life sciences building at 12 Farnsworth St. Tim Lahey of CBRE represented the tenant in the lease negotiations. Eric Smith and Lauren Drakeley, also with CBRE, represented the landlord, Phase 3 Real Estate Partners.

June 24, 2026

Civic Colorado Development Industrial Life Sciences Top Stories Western

Federal Government Agencies Break Ground on $228M Food Lab Near Denver

by Taylor Williams June 22, 2026

LAKEWOOD, COLO. — The U.S. General Services Administration (GSA), U.S. Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) have broken ground on a $228 million food lab in Lakewood, a southwestern suburb of Denver. According to Colorado Politics, the site is located within Denver Federal Center, a complex that spans 4 million square feet of space across 90 buildings. The complex houses operations of 28 federal agencies representing some 6,200 employees, according to the local publication. The new food lab will include 16,500 square feet of new lab space for microbiology functions and 14,000 square feet for chemistry initiatives. The facility will be used to support the FDA’s management of foodborne illness outbreaks and ensure product safety for food, drugs and cosmetics. Completion is slated for 2029. The exterior design of the facility will feature a neoclassical style that reflects President Donald Trump’s executive order to “making federal architecture beautiful again.” The interior of the facility will include controlled access and a sustained directional airflow system. Additionally, the property will be the FDA’s only Biosafety Level 3 facility west of the Mississippi River. “Laboratories are vital to the FDA’s mission to ensure the safety of …

June 22, 2026

Acquisitions Life Sciences Northeast Rhode Island

Newmark Brokers $68M Sale of Life Sciences, Biomanufacturing Facility in Providence

by Taylor Williams June 18, 2026

PROVIDENCE, R.I. — Newmark has brokered the $68 million sale of a life sciences and biomanufacturing facility in Providence. The 122,507-square-foot facility at 100 Technology Way was originally developed in 1993 and was fully leased at the time of sale to Organogenesis (NASDAQ: ORGO), a provider of regenerative medicine solutions. New York City-based investment firm Lightstone acquired the property from local owner-operator The Davis Cos. Robert Griffin, Jim Tribble, Samantha Hallowell, Tyler McGrail and William Sleeper of Newmark brokered the deal. The property is currently in the midst of a $100 million capital improvement program.

June 18, 2026

Leasing Activity Life Sciences New York Northeast

Rover Diagnostics Signs 15,763 SF Life Sciences Lease in Queens

by Taylor Williams June 18, 2026

NEW YORK CITY — Rover Diagnostics has signed a 15,763-square-foot life sciences lease in Queens. The space is located on the ground floor of Innolabs, a 266,800-square-foot development in the borough’s Long Island City area. Tom Burrus of JLL represented Rover Diagnostics in the lease negotiations. Bill Harvey and John Cahill, also with JLL, represented the landlord, a partnership between King Street Properties and GFP Real Estate.

June 18, 2026

Industrial Leasing Activity Life Sciences Office Texas

Telecommunications Firm Signs 42,000 SF Lease at Flex Building in Richardson, Texas

by Taylor Williams June 17, 2026

RICHARDSON, TEXAS — ANDREW, a hardware manufacturer for the telecommunications industry, has signed a 42,000-square-foot lease in the northeastern Dallas suburb of Richardson. The company is relocating from the nearby building at 2601 Telecom Parkway to the flex building at 2920 Telecom Parkway. In addition to office, the company’s new space supports lab, manufacturing and engineering uses. As part of the relocation, ANDREW plans to invest more than $2 million to support tenant improvements and the addition of new furniture, fixtures and equipment at its new Richardson facility.

June 17, 2026

Leasing Activity Life Sciences Massachusetts Northeast

Biocytogen Signs 35,000 SF Life Sciences Lease Expansion in Waltham, Massachusetts

by Taylor Williams June 17, 2026

WALTHAM, MASS. — Biocytogen, which provides animal and cell model generation for preclinical research, has signed a 35,000-square-foot life sciences lease in Waltham, a western suburb of Boston. Biocytogen now occupies about 70,000 square feet at the 143,533-square-foot building at 300 Third Ave. Tim Allen of Colliers represented the tenant in the lease negotiations. Tim Latham, Christopher Scott and Chris Devaux represented the landlord, Dallas-based Lincoln Property Co., on an internal basis.

June 17, 2026

Life Sciences Loans Massachusetts Northeast Office

Joint Venture Refinances 615,305 SF Office, Life Sciences Campus in Bedford, Massachusetts

by Taylor Williams June 4, 2026

BEDFORD, MASS. — A joint venture between Anchor Line Partners and Alloy Properties has refinanced The Core at Crosby, a 615,305-square-foot office and life sciences campus in Bedford, a northwestern suburb of Boston. Berlin Hyp, the commercial real estate finance arm of LBBW, provided the debt for the nine-building campus, which is anchored by software provider AspenTech. Robert Griffin, David Douvadjian Sr., David Douvadjian Jr., Timothy O’Donnell, Edward Maher and Matthew Pullen of Newmark arranged the debt on behalf of the joint venture.

June 4, 2026

Development Life Sciences North Carolina Southeast Top Stories

AbbVie to Invest $1.4B in New Pharmaceutical Manufacturing Facility in Durham, North Carolina

by Hayden Spiess April 23, 2026

DURHAM, N.C. — Biopharmaceutical company AbbVie (NYSE: ABBV) has announced plans for a new pharmaceutical manufacturing campus located in Durham, according to North Carolina Gov. Josh Stein. AbbVie will invest $1.4 billion in the project over four years, marking the company’s largest capital commitment for a single campus to date and its first investment in the Tarheel State. Last year, AbbVie unveiled plans for a $195 million expansion its manufacturing plan in its hometown of North Chicago. Both projects are part of AbbVie’s $100 billion commitment to grow its U.S. research-and-development and capital investments over the next decade. Upon completion, the Durham campus will total 185 acres and will include drug product manufacturing facilities, next-generation laboratories, a warehouse, administrative offices and employee wellness facilities. AbbVie plans to produce small volume parenteral (i.e. prefilled syringes and vials for injection or infusion) drug products at the facility. Construction of the Durham campus is scheduled to begin this year and be completed by the end of 2028. AbbVie expects the construction process to support 2,000 temporary jobs. Several state and local entities, including The North Carolina Department of Commerce and the Economic Development Partnership of North Carolina, have collaborated with AbbVie on the project. AbbVie …

April 23, 2026

Newer Posts

Older Posts